Meimoun Patrick, Benali Tahar, Elmkies Frederic, Sayah Smain, Luycx-Bore Anne, Doutrelan Luc, Hamdane Zemir, Boulanger Jacques, Tribouilloy Christophe
Department of Cardiology and Intensive Care Unit, Centre Hospitalier de Compiègne, 8 rue Henri Adnot, 60200 Compiègne, France.
Eur J Echocardiogr. 2009 Jan;10(1):127-32. doi: 10.1093/ejechocard/jen190. Epub 2008 Jun 25.
Prognostic value of transthoracic coronary flow reserve (T-CFR) is not established in patients with left anterior descending artery (LAD) stenosis of intermediate severity. Objective is to determine the prognosis value of T-CFR>2 in medically treated patients with angiographically intermediate [50-70% QCA (quantitative coronary angiography)] proximal LAD stenosis.
Among 110 consecutive patients with intermediate LAD stenosis who underwent prospectively T-CFR in the distal part of the LAD after intravenous administration of adenosine to assess the functional significance of the stenosis, 80 patients had T-CFR>2 and were treated medically without revascularization (Group 1). Among the 30 patients who had T-CFR<2, an additional dobutamine stress echocardiography (DSE) was performed: 15 had a negative DSE; were treated medically and served as a comparative group (Group 2), and 15 had a positive DSE; underwent LAD revascularization, and were excluded from further analysis. All patients completed follow-up (16+/-10 months). During the follow-up period (range 6-45 months), 76 patients (95%) remained free of death or LAD-related event in Group 1, vs. 12 patients (80%) in Group 2. By Kaplan-Meier method, at 30 months the per cent estimated survival free from death or target vessel-related events was 92+/-4% in Group 1 and 44+/-22% in Group 2 (P<0.01). By multivariate analysis, T-CFR remained the only independent predictor of death or LAD-related events.
In patients with proximal LAD stenosis of intermediate severity and T-CFR>2, deferral of revascularization is associated with low event rate.
对于中度左前降支(LAD)狭窄患者,经胸冠状动脉血流储备(T-CFR)的预后价值尚未明确。本研究旨在确定T-CFR>2对于接受药物治疗、血管造影显示为中度(定量冠状动脉造影显示狭窄50%-70%)近端LAD狭窄患者的预后价值。
连续纳入110例中度LAD狭窄患者,静脉注射腺苷后对LAD远端进行前瞻性T-CFR检测,以评估狭窄的功能意义。其中80例患者T-CFR>2,接受药物治疗,未进行血运重建(第1组)。在30例T-CFR<2的患者中,额外进行了多巴酚丁胺负荷超声心动图(DSE)检查:15例DSE结果为阴性,接受药物治疗,作为对照组(第2组);15例DSE结果为阳性,接受LAD血运重建,被排除在进一步分析之外。所有患者均完成随访(16±10个月)。随访期间(6-45个月),第1组76例患者(95%)无死亡或LAD相关事件,第2组为12例患者(80%)。采用Kaplan-Meier法,30个月时,第1组无死亡或靶血管相关事件的估计生存率为92±4%,第2组为44±22%(P<0.01)。多因素分析显示,T-CFR仍然是死亡或LAD相关事件的唯一独立预测因素。
对于中度严重的近端LAD狭窄且T-CFR>2的患者,延迟血运重建与低事件发生率相关。